v3.10.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
COSTS AND EXPENSES:        
Research and development $ 1,723,087 $ 2,175,929 $ 3,802,955 $ 4,032,810
General and administrative 1,181,832 1,040,540 2,555,491 1,995,896
Total costs and expenses 2,904,919 3,216,469 6,358,446 6,028,706
LOSS FROM OPERATIONS (2,904,919) (3,216,469) (6,358,446) (6,028,706)
OTHER INCOME (EXPENSE):        
(Loss)/Gain on revaluation of derivative warrants (20,000) 90,000 (46,950) 7,525
Interest income, net 4,228 4,941 8,882 8,328
Total other income (expense), net (15,772) 94,941 (38,068) 15,853
NET LOSS $ (2,920,691) $ (3,121,528) $ (6,396,514) $ (6,012,853)
BASIC AND DILUTED NET LOSS PER COMMON SHARE $ (1.69) $ (2.32) $ (3.75) $ (4.72)
SHARES USED IN COMPUTING BASIC AND DILUTED NET LOSS PER COMMON SHARE 1,731,561 1,346,199 1,706,278 1,274,014

Source